TERAPIAS AVANZADAS: DIFERENCIACIÃN, REGENERACIÃN Y CÃNCER
TERADIRECA


Universidad Autónoma de Madrid
Madrid, EspañaPublications in collaboration with researchers from Universidad Autónoma de Madrid (9)
2011
-
Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins
Journal of Virology, Vol. 85, Núm. 24, pp. 12890-12900
2006
-
Antiviral action of the tumor suppressor ARF
EMBO Journal, Vol. 25, Núm. 18, pp. 4284-4292
-
Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action
Microbiology and Molecular Biology Reviews, Vol. 70, Núm. 4, pp. 1032-1060
2005
-
Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus
Experimental Cell Research, Vol. 311, Núm. 1, pp. 96-105
-
Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a Vaccinia virus recombinant
Virology Journal, Vol. 2
2002
-
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L
Oncogene, Vol. 21, Núm. 55, pp. 8379-8387
-
Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: Molecular mechanism and relevance
FEBS Letters, Vol. 529, Núm. 2-3, pp. 249-255
2001
-
The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-κB activation
Oncogene, Vol. 20, Núm. 3, pp. 385-394
1997
-
Increase in plasma thyrotropin levels in hypothyroid patients during treatment due to a defect in the commercial preparation
Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 10, pp. 3192-3195